
Asst. Prof. Univ of Colorado @CU_BMG. Chemist, sometimes structural biologist, bike racer 🚴🏼♂️, 👦 & 🐶 dad, 🇨🇦, 🎓 Stanford/Harvard/UToronto.
Denver, CO
Joined September 2009
- Tweets6.7K
- Following2.4K
- Followers3.2K
- Likes19.1K
John Janetzko retweeted
Nope. Early on one typical comment was “I cannot imagine what this will be useful for” (paraphrase). This was the comment as well from the one question I received when I first presented it at a @GordonConf
Most recently I was told (by kind program officer) “they found your proposal boring” (paraphrase).
So essentially it was disinterest.
I’m not complaining as my lab is funded to do stuff which is very cool.
The program officers have always been kind and supportive. My colleagues…not so much.
John Janetzko retweeted
>be cell biology postdoc at UCLA, 1986
>job: purify vesicles from rat liver
>ez
>purify the vesicles
>something else in the tube
>weird little barrels, way bigger than a ribosome
>fkisdis
>purify the barrels instead
>mostly protein, tiny bit of RNA
>not related to vesicles at all
>new organelle just dropped?
>lab holds a naming contest
>"vaults" "sure, "great name" "
>write it up, publish
>conclusion section: "function: unknown"
>surely we'll figure it out in a couple years
>reviewers: "are you sure this isn't just a virus"
>prove it isn't a virus
>apply for grants to study it
>first question on every call: "what does it do"
>"we're working on it"
>be early 90s
>vaults hang around the nucleus
>"they must plug the nuclear pores"
>they do not
>be different scientist, Netherlands, 1995
>chasing LRP, mystery protein that shows up in chemo-resistant tumors
>clone it
>~88% identical to rat vault protein
>it was vaults the whole time
>whole cancer field piles on
>a decade of papers on vaults and drug resistance
>nobody ever proves vaults cause it
>back at UCLA
>one of the vault proteins binds telomerase
>"guys what if this is the fountain of youth"
>knock it out in mice
>telomeres fine, aging fine, mice fine
>2002
>knock out the main vault protein
>mice: perfectly healthy
>knock out all three vault proteins
>completely vaultless mice
>mice: basically fine, some subtle immune stuff
>mfw something in every cell since the dawn of eukaryotes does nothing obvious
>"just test it in yeast"
>yeast don't have vaults
>"worms then"
>no vaults
>"fruit flies"
>no vaults
>mfw every easy model organism dropped them
>try making recombinant vaults in insect cells
>expecting to get some loose protein at best
>get fully assembled vaults
>can't find a single free copy of the protein anywhere
>turns out ribosomes 3D-print the barrel straight off the mRNA
>lolwut
>still no function
>be structural biologists
>spend years modeling it as 96 proteins with 8-fold symmetry
>2009 X-ray structure
>it's 78 proteins, 39-fold
>caps still blurry
>2025: caps are closed, 13-fold, tiny hole in the middle
>still no function
>NIH funds vault research for 15 years
>NIH: "so what does it do"
>"...we're working on it"
>NIH stops returning calls
>if we can't figure out what it does, we'll make it do something
>stuff a cancer-fighting chemokine inside the barrel
>inject into mouse lung tumors
>immune cells swarm in, tumors shrink
>2011: "human trials within three years"
>2024: "human trials next year"
>2025 database: preclinical
>start a YouTube channel explaining vaults to anyone who'll listen
>be different scientist, Broad Institute
>want to record what genes a cell turned on over time
>try tethering mRNA to a bacterial protein
>doesn't work
>stumble onto a YouTube channel about some obscure barrel organelle
>engineer vaults to grab mRNA
>RNA half-life goes from ~17 hours to ~132 hours
>publish in Science, 2026
>use it to catch drug-resistance genes in lung cancer cells before the drug even hits
>the vault guy is thrilled
>still nobody knows what vaults are for
>be epigeneticists
>screen the whole genome for methylation set at random in the early embryo
>separately study kids conceived in different seasons in rural Gambia
>both screens independently point at the same gene
>it's the goddam vault RNA gene
>its methylation depends on conditions around conception, locked in for life
>linked to cancer outcomes, blood sugar, cleft palate
>mfw the mystery barrel has a mystery RNA that remembers when you were conceived
>40 years later
>one of the most abundant structures in your cells
>still not in a single textbook cell diagram
>we use it anyway because yolo
>function: unknown
>be CNRS scientist in montpellier
>dig through institut curie's chemical library looking for an HIV cure
>find a quinoline that blocks rev from exporting viral RNA
>somehow involved in splicing
>start a company called splicos based on this
>4 years later, company gets merged into abivax
>molecule is now ABX464
>run two phase 2a HIV trials
>it shrinks the viral reservoir a bit
>mfw "a bit" does not cure HIV
>but the bloodwork is weird
>random microRNA miR-124 is cranked tf up
>mfw miR-124 is a major chill pill for inflammation
>turns out the drug grabs the cap-binding complex and splices exactly one random lncRNA
>that lncRNA becomes miR-124
>why that one? lol idk
>HIV attacks GI tract, so maybe give it to colitic mice?
>guts heal lmao
>let's yolo this for ulcerative colitis
>2018 phase 2a works
>let's try with rheumatoid arthritis while we're at this
>2020 covid hits
>"what if it stops cytokine storms"
>yeah let's cure ARDS too lol
>french gov makes it a national research priority
>500 patients in
>2021 trial stopped, does nothing
>stock eats dirt
>ceo: "covid was hyper-acute, chronic inflammation is different, trust me"
>quietly drop rheumatoid arthritis
>go all in on UC
>phase 2b works
>2025 phase 3 induction hits
>stock goes vertical
>2026 maintenance trial: half get remission on drug vs 10 % on placebo
>placebo rate is the lowest ever seen in a trial like this
>NDA to FDA planned late 2026
>mfw a failed HIV drug, a failed covid drug, and a lucky lncRNA might become a blockbuster UC pill
>mfw it took 18 years
John Janetzko retweeted
🧠 💊
This opens up precision, cell type neuromodulation for all kinds of CNS disorders …
Chronic pain should be at the top of this next effort
See: nature.com/articles/s41586-0…
Dreadds work in humans nejm.org/doi/full/10.1056/NE…
John Janetzko retweeted
Dreadds work in humans nejm.org/doi/full/10.1056/NE…
John Janetzko retweeted
Throughout his career, Jon Clardy helped shape the field of natural products. His record of discovering the most influential naturally occurring small molecules is extraordinary and unmatched. He was a humble man, and his kindness and warmth will be deeply missed
John Janetzko retweeted
Hard for me to see someone who was a colleague at MIT relishing in my destruction. Particularly since they barely knew me and never bothered--as perhaps scientists should--to check if there was another version of events.
🚨 BOMBSHELL COURT EVIDENCE EXPOSES EXPLOSIVE PRIVATE MESSAGES REVEALING COORDINATION BETWEEN KRISTIN KNOUSE AND MIT PROFESSOR SANGEETA BHATIA IN THE DAVID M. SABATINI ORDEAL.
🔱 NEW REVELATION — Court evidence exposes how Knouse and Bhatia privately celebrated Sabatini’s removal, discussed the potential destruction of his professional career, and anticipated the revocation of his @MIT tenure.
An 80-message exchange between Kristin Knouse and MIT Professor Sangeeta Bhatia, dated August 20–21, 2021, reveals their private reactions immediately following Whitehead Institute and HHMI's severance of ties with Professor @DMSabatini.
The communications contain statements that deserve serious public examination.
🔴 1. “YOU DID IT” — “AND HE’S OUT.”
On August 20, 2021, Bhatia congratulated Knouse:
🔴 “YOU DID IT. You crossed the finish line. It's out in the open. And you're not out in the open. And you're on the faculty. And he's out.”
Knouse responded:
🔴 “You connecting me to Nancy [Hopkins]was the turning point. I will never forget that walk in Lexington.”
🔴 2. “THIS WAS THE OUTCOME I DREAMED OF.”
The following morning, as news coverage spread, Knouse discussed the possibility of Sabatini losing his MIT tenure:
🔴 “Hard to imagine MIT will be left with any choice other than to revoke tenure.”
Bhatia responded:
🔴 “You're right about tenure”
She subsequently wrote:
🔴 “This was the outcome I dreamed of but NEVER certain I would get it.”
Knouse also described her assessment of Whitehead's handling of the matter:
🔴 “And as skeptical as I was of Whitehead's end game, in the end I think the overall process was perfectly executed.”
Bhatia expressed her approval of Whitehead Institute Director Ruth Lehmann:
🔴 “I'm proud of Ruth [Lehmann]”
These exchanges occurred months before MIT's April 2022 tenure-revocation recommendation.
🔴 3. THE PROFESSIONAL CONSEQUENCES — BEYOND WHITEHEAD.
The participants also discussed Sabatini's corporate affiliations and prospects for future employment.
Knouse wrote:
🔴 “I know of one company already speaking with lawyers to remove him on grounds of morality clause.”
She subsequently stated:
🔴 “Hard to imagine how he can be gainfully employed anywhere after the past 24 hours ...”
These were not merely discussions about an institutional investigation. They extended to the potential consequences for Sabatini's career, tenure, corporate affiliations, and future livelihood.
🔴 4. THE DIVERSITY SURVEY AND PROTECTION FROM PUBLIC IDENTIFICATION.
In another particularly consequential exchange, Bhatia wrote:
🔴 “Also the dei survey and subsequent investigation really protects you, which I love. There is not even a scent of whistleblower in all the press.”
This statement takes on particular significance alongside the previously disclosed communications in which Knouse and Nora Kory discussed using Whitehead's diversity survey to conceal an investigation already under consideration (📑 see the original court evidence in the first comment below).
🔴 5. “WE DRANK CHAMPAGNE” — CELEBRATING AS THE NEWS SPREAD.
Perhaps the most striking exchange appears on KK011419.
On August 21, 2021, Knouse declared:
🔴 “I KNOW! Young people took down a relatively young king. Progress, progress, progress.”
Knouse also wrote:
🔴 “Two other women who came forward and I drank champagne while watching the Tweets and articles roll in last night. It felt like campaign headquarters after an election victory. Really special.”
Bhatia responded:
🔴 “That's awesome.”
These exchanges reinforce the serious concerns about coordination and conflicts of interest raised by our previous disclosures. Their significance must be assessed alongside the full documentary record and the subsequent jury verdict.
The scientific community deserves full accountability for any misconduct established by the evidence, including the roles of individuals who participated in or improperly influenced the institutional processes that subjected Professor Sabatini to a devastating ordeal and profoundly damaged his career.
📑 REVIEW THE ORIGINAL COURT EVIDENCE BELOW.
🔱 ScienceGuardians™ Legal and Investigative Team
MORE COURT EVIDENCE. MORE REVELATIONS. STAY TUNED. ⚠️
@SciGuardians 🔱
John Janetzko retweeted
Today I smiled for real for the first time in more than 5 years. Thank you to the jury, judge, court officer and clerk. And of course to my rockstar legal team. I truly wish the best for everyone involved.
A civil jury ruled in favor of ex-MIT scientist David Sabatini, who was accused by a younger colleague of inappropriate sexual conduct in his Cambridge research lab, and awarded him $6 million in damages. trib.al/s3v9VIX
John Janetzko retweeted
500 million people - 6% of humanity -are G6PD deficient. G6PD is key to cancer, aging & exercise, but >230 variants remain poorly understood.
New preprint: “Structural divergence of G6PD variants shapes red blood cell storage and transfusion performance”
biorxiv.org/content/10.1101/…
John Janetzko retweeted
If the Irkutsk researcher died of plague, she was presumably unvaccinated and did not receive antibiotics per protocol. Alternatively, the strain was vaccine-evading and antibiotic-resistant. That seldom occurs naturally. Pneumonic plague is only moderately transmissible.
1/5
John Janetzko retweeted
Russia's five-hospital quarantine, FSB involvement, and reported hazmat use in response to the death of a single researcher at a weapons-lineage Irkutsk lab are inconsistent with a lab-acquired plague infection, which would have been treated with prophylactic antibiotics.
1/4
Ahhhhhhhhh!!! Congrats to @KarlDeisseroth 🎉 this was not unexpected but it’s so amazing to see it. Wishing I was at Stanford right now to experience the energy and joy.
BREAKING NEWS
The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
John Janetzko retweeted
Do you use self-labeling proteins (SLPs) like HaloTag and SNAP-tag? Then check out Jody's new preprint to learn about LUCI-tag! Jody built LUCI-tag starting from K-Ras(G12C), using protein design to erase K-Ras from biology 🤯!
Excited to share a preprint of my main PhD work in @nickpolizzi_'s lab - introducing LUCI-tag, a new orthogonal self-labeling protein tag based on K-Ras(G12C) and its covalent inhibitors! biorxiv.org/content/10.64898… (1/16)
John Janetzko retweeted
My department is hiring for a tenure-track faculty position in neuroscience! 👇
nature.com/naturecareers/job…
John Janetzko retweeted
Lilly's acquisition of Merida is remarkable. You gotta love seeing big pharma take bets on innovative science like this. Feels like we are about to see some big battles between 'immune reset' and precision autoantibody deletion. Patients win either way!
John Janetzko retweeted
1/3 Exciting News! We're hiring at all levels immediately for our lab @UUNeurobiology Join us in cutting-edge research at the intersection of neuroscience and chemical biology! We aim to explore how neuropeptides modulate behavior and physiology.
Pls RT!
John Janetzko retweeted
Very cool paper!
Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity
nature.com/articles/s41467-0…
John Janetzko retweeted
It’s been an extremely strange past few months in the Panda lab. Rumours, gossip, secrecy, lies, manipulation. It’s been confusing, taxing, and relentless for all of us (to say nothing of what it must’ve been like for the most recent victim!).
Very grateful to @Sara_Reardon for her reporting on this and to @salkinstitute for handling things as well as they could, given legal constraints. Since I do not represent Salk, I am able to speak more freely. This article is extremely fair. There are plenty of other examples of bullying and abuse that will probably never see light of day.
Hopefully some transparency brings a sense of justice to the victims and normalcy to us remaining lab members. It might also help funding bodies decide whether to leave grant money with the lab members actually doing the work at Salk, or whether to give it to Satchin. I know that he has already tried to persuade @WuTsaiAlliance to do the latter, before these allegations were made public.
It’s remarkable that many of my colleagues in the lab will be finding out about some of the details here for the first time today. The secrecy and confusion, combined with good individual relationships with Satchin and a fear of career-death, has led many to defend him loyally. Everyone is entitled to their perspective. Allowing everyone to form that perspective free from persuasion by Satchin and with full knowledge of events seemed to me to be the right thing to do.
Exclusive: Satchidananda Panda, a prominent biologist known for his work on circadian rhythms, light sensing, and intermittent fasting, will resign next month after 22 years at the Salk Institute for Biological Studies. scim.ag/3RjNpLG
Some days people in the lab work hard on their science…
Other days, they spend time making a South Park themed version of the lab photo…
#newPIlife
2
399
John Janetzko retweeted
Anthropic is a drug company now. Of course their models are too dangerous for biology. It's unsafe for Anthropic if their competitors can use them.
In all seriousness, the conflict of interest makes it difficult for any biotech/pharma to continue to use their models.


























